RICHARD G. VINCENT

Insider Reports History

Location
San Diego, CA
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by RICHARD G. VINCENT:

Company Role Class Num Shares Value Price $ Report Date Ownership
Oncternal Therapeutics, Inc. Chief Financial Officer Common Stock 140,922 $69,911 $0.4961 03 Jan 2024 Direct
Oncternal Therapeutics, Inc. Chief Financial Officer Common Stock 4,526 $2,245 $0.4961 03 Jan 2024 By Family Trust
Oncternal Therapeutics, Inc. Chief Financial Officer Common Stock 1,834 $910 $0.4961 03 Jan 2024 By Child
Forte Biosciences, Inc. Director Stock Option (right to buy) 31,000 20 Mar 2025 Direct
Oncternal Therapeutics, Inc. Chief Financial Officer Stock Option 14,200 14 Feb 2024 Direct

Insider Reports Filed by RICHARD G. VINCENT

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FBRX Forte Biosciences, Inc. 20 Mar 2025 1 $0 4 Director 21 Mar 2025, 16:50
FBRX Forte Biosciences, Inc. 17 Sep 2024 1 $0 4 Director 19 Sep 2024, 18:30
FBRX Forte Biosciences, Inc. 17 Sep 2024 0 $0 3 Director 19 Sep 2024, 18:26
/report/000120919124003408-vincent-richard-g-2024-02-14 Oncternal Therapeutics, Inc. 14 Feb 2024 1 $0 4 Chief Financial Officer 15 Feb 2024, 18:00
/report/000120919124000972-vincent-richard-g-2024-01-03 Oncternal Therapeutics, Inc. 03 Jan 2024 1 -$4,399 4 Chief Financial Officer 05 Jan 2024, 16:00
/report/000120919123052015-vincent-richard-g-2023-10-02 Oncternal Therapeutics, Inc. 02 Oct 2023 12 $0 4 Chief Financial Officer 04 Oct 2023, 16:59
/report/000120919123041316-vincent-richard-g-2023-07-03 Oncternal Therapeutics, Inc. 03 Jul 2023 1 -$2,545 4 Chief Financial Officer 05 Jul 2023, 18:58
/report/000120919123024263-vincent-richard-g-2023-04-13 Oncternal Therapeutics, Inc. 13 Apr 2023 1 +$8,961 4 Chief Financial Officer 14 Apr 2023, 06:00
/report/000120919123012396-vincent-richard-g-2023-02-21 Oncternal Therapeutics, Inc. 21 Feb 2023 1 $0 4 Chief Financial Officer 23 Feb 2023, 19:00
/report/000120919123002028-vincent-richard-g-2023-01-03 Oncternal Therapeutics, Inc. 03 Jan 2023 1 -$4,517 4 Chief Financial Officer 05 Jan 2023, 17:00
/report/000120919122043736-vincent-richard-g-2022-07-28 Oncternal Therapeutics, Inc. 28 Jul 2022 2 $0 4 Chief Financial Officer 01 Aug 2022, 18:19
/report/000120919122021302-vincent-richard-g-2022-03-24 Oncternal Therapeutics, Inc. 24 Mar 2022 5 +$7,210 4 Chief Financial Officer 28 Mar 2022, 16:00
/report/000120919122005559-vincent-richard-g-2022-01-27 Oncternal Therapeutics, Inc. 27 Jan 2022 3 +$21,625 4 Chief Financial Officer 31 Jan 2022, 15:00
/report/000120919122004585-vincent-richard-g-2022-01-20 Oncternal Therapeutics, Inc. 20 Jan 2022 1 $0 4 Chief Financial Officer 24 Jan 2022, 15:00
/report/000120919122001971-vincent-richard-g-2022-01-03 Oncternal Therapeutics, Inc. 03 Jan 2022 1 $0 4 Chief Financial Officer 05 Jan 2022, 18:00